AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

DILTIAZEM HYDROCHLORIDE

11 registrations across 5 African markets— 7 active

Markets with DILTIAZEM HYDROCHLORIDE

🇿🇦South Africa
7 registrations
4 active
🇲🇼Malawi
1 registration
0 active
🇳🇬Nigeria
1 registration
1 active
🇹🇿Tanzania
1 registration
1 active
🇿🇲Zambia
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
Diltigesic Gel
Gel
🇿🇲ZambiaTroikaa Pharmaceuticals LtdactiveSept 2029
Dilcontin XL 120**
Tablet
🇳🇬NigeriaPhillips Pharmaceuticals (Nigeria) LimitedactiveJan 2026
DILATAM 30 mg🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedJul 2024
DILEM 60 mg🇿🇦South AfricaACINO PHARMA (PTY) LTDsuspendedDec 2023
DILEM 30 mg🇿🇦South AfricaACINO PHARMA (PTY) LTDsuspendedDec 2023
TILAZEM 60MG TABLET
TABLET
🇲🇼Malawi—expiredJun 2004
ADCO-ZILDEM 240 SR🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
ADCO ZILDEM 90🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
ADCO-ZILDEM 180 SR🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
DILATAM 60 mg🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
Diltiazem Hydrochloride Tablets USP 60 mg
Oral tablet
🇹🇿TanzaniaBDA HEALTHCARE PVT LTDactive—

DILTIAZEM HYDROCHLORIDE in Africa — Regulatory Overview

DILTIAZEM HYDROCHLORIDE is registered across 5 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Malawi, Nigeria, Tanzania and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 7 (64%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.